Join Clinicians Worldwide
Evidence‑based insights to enhance hearing care—twice a month
Subscribe Now
Evidence‑based insights to enhance hearing care—twice a month
Subscribe Now
Professor Mario Zernotti, our guest author, shares insights gained from nearly four decades of experience helping children with conductive hearing loss due to microtia and congenital aural atresia, which occurs most commonly in Andes Mountains of South America.
After receiving several hearing solutions that had no lasting success, a 13-year-old from Spain received bilateral active, transcutaneous BONEBRIDGE implants. In this case report, surgeons Dr. Estefanía Berrocal and Dr. Francisco Javier Aguilar explain the challenges associated with replacing an old implant and why the BONEBRIDGE implant is their "first choice for children."
For over five years, ADHEAR has been available as a treatment option to people of all ages with unilateral or bilateral conductive hearing loss, whether chronic or temporary. As a non-surgical bone conduction device, ADHEAR has been shown to provide children and adults with immediate hearing improvements. Celebrating Over Five Years of ADHEAR To
People with Congenital Microtia-Atresia (CMA) have malformations of the pinna and the external auditory canal. Often the middle ear anatomy is also affected and shows abnormalities. The vast majority of children born with CMA have moderate to severe conductive hearing loss from the very beginning of their lives. We all know that this has an